⌘K

Home/Filings/4/0001516551-21-000014

4//SEC Filing

Arsenault Kaitlyn Melanie 4

Accession 0001516551-21-000014

CIK 0001516551other

View on SEC.gov Company Profile

Filed

Oct 4, 8:00 PM ET

Accepted

Oct 5, 8:42 PM ET

Size

5.7 KB

Accession

0001516551-21-000014

Insider Transaction Report

Form 4

Period: 2021-10-04

Skye Bioscience, Inc.SKYE

ARSENAULT KAITLYN

Chief Financial Officer

Transactions

Award
Employee Stock Option (Right to Buy)
2021-10-04+1,600,000→ 2,000,000 total
Exercise: $0.09Exp: 2031-10-04→ Common Stock (1,600,000 underlying)

Footnotes (1)

[F1]10% of the Options shall vest on October 4, 2021 (the "Vesting Start Date") and the remaining 90% of the Options will vest in equal semi-annual installments over four annual periods.

Documents

1 file

4
wf-form4_163348095684882.xmlPrimary
FORM 4

Issuer

Skye Bioscience, Inc.

CIK 0001516551

Entity typeother

Related Parties

1

filerCIK 0001877242

Filing Metadata

Form type: 4
Filed: Oct 4, 8:00 PM ET
Accepted: Oct 5, 8:42 PM ET
Size: 5.7 KB

View on SEC.gov